norfloxacin has been researched along with Chronic Bullous Disease of Childhood in 1 studies
Norfloxacin: A synthetic fluoroquinolone (FLUOROQUINOLONES) with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin inhibits bacterial DNA GYRASE.
norfloxacin : A quinolinemonocarboxylic acid with broad-spectrum antibacterial activity against most gram-negative and gram-positive bacteria. Norfloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Jakhar, D | 1 |
Singal, A | 1 |
Sharma, S | 1 |
Kotru, M | 1 |
1 other study available for norfloxacin and Chronic Bullous Disease of Childhood
Article | Year |
---|---|
Norfloxacin-Induced Linear IgA Dermatosis.
Topics: Anti-Infective Agents; Humans; Linear IgA Bullous Dermatosis; Male; Middle Aged; Norfloxacin | 2020 |